Alkem Laboratories Limited Alkem Laboratories Limited

Alkem Laboratories Limited

ALKEM

Rang in Aktien #2892
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Aktienkurs
$52.51
Marktkapitalisierung
$6.28B
Veränderung (1 Tag)
-4.86%
Veränderung (1 Jahr)
-16.69%
Land
IN
Handel Alkem Laboratories Limited (ALKEM)

Kategorie

Healthcare
Kursverlauf für Alkem Laboratories Limited (ALKEM)
Höchster Schlusskurs: $56.92 am 2026-10-01

Niedrigster Schlusskurs: $22.12 am 2015-12-01
Kursverlauf der Aktie von Alkem Laboratories Limited von 2015 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -2.37%
2025 -3.89%
2024 10.58%
2023 57.10%
2022 -18.82%
2021 16.83%
2020 36.17%
2019 8.12%
2018 -19.55%
2017 37.25%
2016 9.22%
2015 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$165.31 23.62%
DE
$40.45 43.11%
JP
$224.81 31.28%
CH
$18.43 -4.03%
IN